Medicine and Dentistry
ANCA Associated Vasculitis
100%
Hazard Ratio
36%
Cardiovascular System
28%
Cardiovascular Disease
23%
Vasculitis
21%
Prevalence
21%
Cohort Analysis
20%
Myeloperoxidase
19%
Anticoagulation
19%
Immunoglobulin A Nephropathy
19%
Urinary System
19%
Nephrotic Syndrome
19%
Thromboembolism
19%
Patient-Reported Outcome
19%
Kidney Injury
19%
Systemic Lupus Erythematosus
19%
ECG Abnormality
19%
Electrocardiogram
19%
Nephropathy
19%
Biopsy
19%
Systematized Nomenclature of Medicine
19%
End Stage Renal Disease
17%
Cardiovascular Mortality
15%
Renal Biopsy
10%
Implantable Automatic Defibrillator
10%
Complement Factor H
10%
Chronic Kidney Disease
10%
Diabetic Nephropathy
9%
Glomerulopathy
9%
Heart Ventricle Arrhythmia
9%
Diseases
8%
Kidney Function
7%
Visual Analog Scale
7%
Cumulative Incidence
6%
Systemic Disease
6%
Tubulointerstitial Disease
6%
Vascular Disease
6%
Cohort Effect
6%
Heart Arrest
6%
Atrial Fibrillation
6%
Disease Activity
5%
Heart Failure
5%
Brain Ischemia
5%
Keyphrases
ANCA-associated Vasculitis
48%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
38%
Anti-glomerular Basement Membrane Disease
19%
Proximal Tubule Dysfunction
19%
Increased Incidence
19%
Binding Cleft
19%
Long-term Cardiovascular Outcomes
19%
Outcome Trends
19%
PR3-ANCA
19%
Confidence Interval
19%
Cardiovascular Disease Risk
19%
Proteinase 3
19%
Improved Survival
19%
Autoimmune Vasculitis
19%
Antibody-associated
17%
Proteinase-3 Antibodies
13%
Myeloperoxidase Antibodies
12%
Hazard Ratio
12%
Complement Factor H
10%
Kidney Biopsy
9%
DPB1
8%
Major Adverse Cardiovascular Events
7%
Cardiovascular Outcomes
7%
Mean Standard Deviation
6%
Absolute Risk
6%
End-stage Renal Disease
6%
Risk Ratio
6%
Antibody Test
6%
Antineutrophil Cytoplasmic Antibody
6%
Renal Vascular Disease
6%
Cardiovascular Disease
5%
